Evan W. Weber

3.8k total citations · 4 hit papers
19 papers, 1.7k citations indexed

About

Evan W. Weber is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Evan W. Weber has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Evan W. Weber's work include CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (4 papers) and Nanowire Synthesis and Applications (4 papers). Evan W. Weber is often cited by papers focused on CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (4 papers) and Nanowire Synthesis and Applications (4 papers). Evan W. Weber collaborates with scholars based in United States, Norway and New Zealand. Evan W. Weber's co-authors include Crystal L. Mackall, Marcela V. Maus, Elena Sotillo, Rachel C. Lynn, John Lattin, Robbie G. Majzner, Peng Xu, Peng Xu, Ansuman T. Satpathy and David Gennert and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Evan W. Weber

18 papers receiving 1.6k citations

Hit Papers

c-Jun overexpression in CAR T cells induces exhaustion re... 2019 2026 2021 2023 2019 2020 2020 2023 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan W. Weber United States 11 1.3k 622 578 491 336 19 1.7k
Mythili Koneru United States 13 1.3k 1.0× 769 1.2× 440 0.8× 381 0.8× 344 1.0× 29 1.7k
Kelsey M. Wanhainen United States 10 1.7k 1.3× 776 1.2× 551 1.0× 582 1.2× 436 1.3× 14 1.9k
Meenakshi Hegde United States 13 1.4k 1.1× 538 0.9× 414 0.7× 607 1.2× 423 1.3× 36 1.6k
Donald R. Shaffer United States 12 1.4k 1.1× 730 1.2× 417 0.7× 485 1.0× 377 1.1× 23 1.8k
Araceli Naranjo United States 8 1.3k 1.0× 610 1.0× 335 0.6× 484 1.0× 420 1.3× 14 1.5k
Jamie R. Wagner United States 11 1.5k 1.1× 625 1.0× 410 0.7× 570 1.2× 476 1.4× 28 1.8k
Robert C. Sterner United States 6 1.3k 1.0× 746 1.2× 616 1.1× 451 0.9× 310 0.9× 12 1.9k
Andrea Schmidts United States 15 1.3k 1.0× 520 0.8× 762 1.3× 542 1.1× 446 1.3× 30 1.8k
Mark B. Leick United States 16 1.4k 1.1× 518 0.8× 526 0.9× 505 1.0× 408 1.2× 47 1.8k
Jason Plotkin United States 8 1.6k 1.3× 778 1.3× 603 1.0× 569 1.2× 499 1.5× 8 2.0k

Countries citing papers authored by Evan W. Weber

Since Specialization
Citations

This map shows the geographic impact of Evan W. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan W. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan W. Weber more than expected).

Fields of papers citing papers by Evan W. Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan W. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan W. Weber. The network helps show where Evan W. Weber may publish in the future.

Co-authorship network of co-authors of Evan W. Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Evan W. Weber. A scholar is included among the top collaborators of Evan W. Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan W. Weber. Evan W. Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mueller, Katherine P., Jeremy Grenier, & Evan W. Weber. (2025). CAR T cell persistence in cancer. Trends in cancer. 11(10). 1005–1018. 1 indexed citations
2.
Žák, Jaroslav, Wenjian Wang, Ke Qin, et al.. (2024). Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy. Cancer Immunology Research. 13(1). 47–65. 7 indexed citations
3.
Chen, Yingshi, et al.. (2024). 235 Defining the role of TCF1 in CAR T cell memory and persistence. Regular and Young Investigator Award Abstracts. A270–A270.
4.
Tousley, Aidan M., Maria Caterina Rotiroti, Louai Labanieh, et al.. (2023). Co-opting signalling molecules enables logic-gated control of CAR T cells. Nature. 615(7952). 507–516. 170 indexed citations breakdown →
5.
Fu, Tao, David P. Sullivan, Annette M. Gonzalez, et al.. (2023). Mechanotransduction via endothelial adhesion molecule CD31 initiates transmigration and reveals a role for VEGFR2 in diapedesis. Immunity. 56(10). 2311–2324.e6. 23 indexed citations
6.
Lamarche, Caroline, Kirsten A. Ward‐Hartstonge, Mi Tian, et al.. (2023). Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion. Proceedings of the National Academy of Sciences. 120(14). e2219086120–e2219086120. 37 indexed citations
7.
Majzner, Robbie G., Skyler P. Rietberg, Elena Sotillo, et al.. (2020). Tuning the Antigen Density Requirement for CAR T-cell Activity. Cancer Discovery. 10(5). 702–723. 319 indexed citations breakdown →
8.
Dalal, Prarthana, David P. Sullivan, Evan W. Weber, et al.. (2020). Spatiotemporal restriction of endothelial cell calcium signaling is required during leukocyte transmigration. The Journal of Experimental Medicine. 218(1). 17 indexed citations
9.
Weber, Evan W., Marcela V. Maus, & Crystal L. Mackall. (2020). The Emerging Landscape of Immune Cell Therapies. Cell. 181(1). 46–62. 294 indexed citations breakdown →
10.
Lynn, Rachel C., Evan W. Weber, Elena Sotillo, et al.. (2019). c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 576(7786). 293–300. 514 indexed citations breakdown →
11.
Weber, Evan W., Rachel C. Lynn, Elena Sotillo, et al.. (2019). Pharmacologic control of CAR-T cell function using dasatinib. Blood Advances. 3(5). 711–717. 166 indexed citations
12.
Majzner, Robbie G., Skyler P. Rietberg, Louai Labanieh, et al.. (2018). Low CD19 Antigen Density Diminishes Efficacy of CD19 CAR T Cells and Can be Overcome By Rational Redesign of CAR Signaling Domains. Blood. 132(Supplement 1). 963–963. 7 indexed citations
13.
Weber, Evan W. & William A. Müller. (2017). Roles of transient receptor potential channels in regulation of vascular and epithelial barriers. Tissue Barriers. 5(2). e1331722–e1331722. 9 indexed citations
14.
Winger, Ryan C., Christopher Harp, Ming‐Yi Chiang, et al.. (2016). Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell–Mediated Central Nervous System Autoimmune Disease. The Journal of Immunology. 196(4). 1443–1448. 25 indexed citations
15.
Weber, Evan W., et al.. (2015). CD99-like 2 (CD99L2)-deficient mice are defective in the acute inflammatory response. Experimental and Molecular Pathology. 99(3). 455–459. 7 indexed citations
16.
Weber, Evan W., et al.. (2015). TRPC6 is the endothelial calcium channel that regulates leukocyte transendothelial migration during the inflammatory response. The Journal of General Physiology. 146(5). 1465OIA59–1465OIA59. 3 indexed citations
17.
Müller, William A., Sabrina Dominici, Richard Watson, et al.. (2014). Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system. Journal of Immunological Methods. 408. 35–45. 7 indexed citations
18.
Cuda, Carla M., Hemant Agrawal, Alexander V. Misharin, et al.. (2011). Requirement of myeloid cell–specific Fas expression for prevention of systemic autoimmunity in mice. Arthritis & Rheumatism. 64(3). 808–820. 17 indexed citations
19.
Mavers, Melissa, Carla M. Cuda, Alexander V. Misharin, et al.. (2011). Cyclin‐dependent kinase inhibitor p21, via its C‐terminal domain, is essential for resolution of murine inflammatory arthritis. Arthritis & Rheumatism. 64(1). 141–152. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026